Qual é o preço para Homology Medicines, Inc. (FIXX)

O preço para Homology Medicines, Inc. (FIXX) é $0.9347

Qual é a capitalização de mercado para Homology Medicines, Inc. (FIXX)

A capitalização de mercado para Homology Medicines, Inc. (FIXX) é $300.42K

Homology Medicines, Inc. (FIXX) Índice P/VPA

Homology Medicines, Inc. is a biotechnology firm dedicated to genetic therapeutics, striving to enhance the well-being of patients battling rare inherited disorders. The company leverages its unique platform, which employs adeno-associated virus vectors (AAVHSCs) originating from human hematopoietic stem cells, to introduce genetic treatments directly into the body. This approach facilitates either gene therapy or nuclease-free gene editing solutions for a range of genetic ailments. Crucially, Homology's diverse collection of AAVHSCs enables the precise targeting of multiple disease-affected tissues—such as the liver, central and peripheral nervous systems, bone marrow, heart, skeletal muscles, and eyes—all from a single administration. The leading candidate in their pipeline, HMI-102, is a gene therapy undergoing the Phase 2 pheNIX clinical trial, intended for adult patients with phenylketonuria (PKU). Beyond this, their development portfolio includes HMI-103 for pediatric PKU, HMI-202 targeting metachromatic leukodystrophy, HMI-203 for mucopolysaccharidosis type II, and HMI-104 designed to address paroxysmal nocturnal hemoglobinuria. Established in 2015, Homology Medicines, Inc. maintains its corporate headquarters in Bedford, Massachusetts.

Ano	Rácio P/B	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

Rácio P/B

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	Rácio P/B	Diferença do rácio P/B	País
Vertex Pharmaceuticals Incorporated VRTX.US	6.2613	-	US
Argenx SE ARGX.US	6.3483	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	3.634	-	BE

Empresa

Rácio P/B

Diferença do rácio P/B

País